 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Wave Life Sciences (WVE Research Report), Passage Bio...

Analysts' Top Healthcare Picks: Wave Life Sciences (WVE), Passage Bio (PASG)

In a report released today, Joon Lee from Truist Financial maintained a Buy rating on Wave Life Sciences (WVE Research Report). The company's sha...

Truist Financial Reaffirms Their Buy Rating on Wave Life Sciences (WVE)

This is a signal that WVE's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options...

Wave Life Sciences (WVE, $6.17) Stochastic Oscillator left the oversold zone on March 28, 2024

CAMBRIDGE, Mass., March 27, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to...

Wave Life Sciences to Present at Upcoming Investor Conferences

This indicator may be signaling that WVE's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

Wave Life Sciences (WVE, $6.17) entered Downtrend as Momentum indicator drops below 0 level on Mar 20, 2024

This is a Bearish indicator signaling WVE's price could decline from here. Traders may explore shorting the stock or put options...

Wave Life Sciences (WVE, $5.93) Moving Average Convergence Divergence (MACD) Histogram turned negative on March 19, 2024

This is a signal that WVE's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...

Wave Life Sciences (WVE, $6.42) RSI Indicator left the overbought zone on March 14, 2024

This is a signal that WVE's price trend could be reversing, and it may be an opportunity to sell the stock or take a defensive position...

Wave Life Sciences (WVE, $6.84) Stochastic Oscillator left the overbought zone on March 13, 2024

This price move could be a signal that WVE may fall back below the higher band and head toward the middle band. Traders may consider selling the stock, shorting the stock, or exploring put options...

Wave Life Sciences (WVE, $6.31) price may drop as it broke higher Bollinger Band on Mar 06, 2024

Wave Life Sciences (WVE, $6.31) RSI Indicator left the overbought zone on March 06, 2024

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Volume (M)	538,925.00
52-Wk High	$7.67
52-Wk Low	$3.15

WVE Wave Life Sciences Ltd.

About

Feed

News

Sentiment

Earnings

Fundamentals